Tag: Aspirin

Aspirin discontinuation at 24 to 28 weeks gestation noninferior to continuation until 36 weeks of gestation

No significant difference seen in incidence of death, deep vein thrombosis, pulmonary embolism, bleeding complications

Protection against aspirin-associated peptic ulcer bleeding in older adults lost after the first 2.5 years

Stroke patients with normal, but not those with impaired, renal function have greater benefit with ticagrelor-aspirin than clopidogrel-aspirin

Quality improvement effort tied to decrease in major bleeding without increase in thrombotic events

Association remains regardless of the presence of most other risk factors for ovarian cancer

Statin use linked to reduced risk for major adverse cardiovascular events in individuals with nonobstructive coronary artery disease

For those aged 40 to 59 years, the decision to initiate low-dose aspirin for primary prevention of CVD should be individualized

Largest benefits seen for patients older than 60 years with no increased risk for hemorrhagic complications

Findings inconclusive for subgroup analysis looking at safety of ceasing regular aspirin use without a clinical indication after age 70 years